Delivering genetic screening to the community

Annals of Medicine

Volumn 29, Issue 6, 1997, Pages 591-599

  Modell, Bernadette ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

Audit; Community genetics; Genetic screening; Information; Prevention; Sickle cell; Thalassaemia

Indexed keywords

COMMUNITY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DISEASE CARRIER; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; INFORMATION; MEDICAL AUDIT; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SICKLE CELL TRAIT; THALASSEMIA;

EID: 0031409995     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899709007488     Document Type: Conference Paper

References (24)

1. NHO Hereditary Disease Programme. Guidelines for the Control of Haemoglobin Disorders. Unpublished document of the WHO, 1995. WHO/HDP/GL/94.1.
2. Petrou M, Brugiatelli M, Old J, et al. Alpha thalassaemia hydrops fetalis in the UK: the importance of screening pregnant women of Chinese, other South East Asian and Mediterranean extraction for alpha thalassaemia trait. Br J Obstet Gynaecol 1992; 99: 985-9.
3. Cao A, Gabutti V, Galanello R, Masera G, et al. Management Protocol for the Treatment of Thalassaemia Patients. Cyprus, Nicosia: Thalassaemia International Federation (TIF), 1997.
4. Serjeant GR. Sickle Cell Disease, 2nd edn. Oxford: Oxford University Press, 1992.
5. British Society for Haematology. Guidelines for haemoglobinopathy screening. Clin Lab Haematol 1988; 10: 87-94.
6. Cao A, Rosatelli C. Screening and prenatal diagnosis of the haemoglobinopathies. Ballieres Clin Haematol 1993; 6: 263-86.
7. Modell B, Petrou M, Ward RHT, et al. Effect of fetal diagnostic testing on the birth-rate of thalassaemia in Britain. Lancet 1985; 2: 1383-6.
8. Old JM, Ward RHT, Petrou M, Karagozlu F, Modell B, Weatherall DJ. First-trimester fetal diagnosis for the haemoglobinopathies: three cases. Lancet 1982; ii: 1413-6.
9. Petrou M, Modell B. Prenatal screening for haemoglobin disorders. Prenat Diagn 1995; 15: 1275-95.
10. Petrou M, Brugiatelli M, Ward RHT, Modell B. Factors affecting the uptake of prenatal diagnosis for sickle cell disease. J Med Genet 1992; 29: 820-3.
11. Report of a Working Party of the Standing Medical Advisory Committee on Sickle Cell, Thalassaemia and other Haemoglobinopathies. London: Her Majesty's Stationery Office, 1994.
12. Anionwu EN. Ethnic origin of sickle and thalassaemia counsellors; does it matter? In: Kelleher D, Hillier S, eds. Research in Cultural Differences in Health. London: Routledge, 1996: 160-89.
13. Coleman D, Salt J, eds. Ethnicity in the 1991 Census. Vol 1. Demographic Characteristics of the Ethnic Minority Populations. London: Office of Population Censuses and Surveys, 1996.
14. Livingstone FA. Frequencies of Hemoglobin Variants. New York: Oxford University Press, 1985.
15. Modell B. EC concerted action on developing patient registers as a tool for improving service delivery for haemoglobin disorders. In: Fracchia GN, Theophilatou M, eds. Health Services Research. Amsterdam: IOS Press, 1993.
16. Health Education Authority. Sickle Cell and Thalassaemia: Achieving Health Gain. London: Her Majesty's Stationery Office (in press).
17. World Health Organization. Community Approaches to the Control of Hereditary Diseases. Report of a WHO Advisory Group on Hereditary Diseases, Geneva 3-5 October 1985. Unpublished WHO document HMG/AG/ 85.10.
18. Modell B. EC Concerted Action on Developing patients registers as a tool for improving service delivery for haemoglobulin disorders. In: Fracchia GN, Theofilaton M. Health Services Research, Amsterdam: IOS Press; 1993: 178-208.
19. Harris R, Williamson P. Confidential enquiry into counselling for genetic disorders. J R Coll Physicians Lond 1996; 30: 316-7.
20. Modell B, Petrou M, Layton M, et al. Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years. BMJ 1997; 115: 779-84.
21. Modell B, Kuliev AM, Wagner M. Community Genetics Services in Europe. WHO Regional Publications, European Series No 38. Copenhagen: WHO Regional Office for Europe, 1992.
22. Modell B, Kuliev AM. A scientific basis for cost-benefit analysis of genetics services. Trends Genet 1993; 9: 46-52.
23. Neuenschwander H, Modell B. Audit of process of antenatal screening for sickle cell disorders at a Northern London Hospital. BMJ 1997; 115: 784-5.
24. Vullo C, Modell B, Georganda, E. What is Thalassaemia? 2nd edn. Nicosia: The Thalassaemia International Federation, 1995.